Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

Journal of Hematology & Oncology | ResearchHub - ResearchHub

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

ResearchHub

Research, connected

Explore the graph

X

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Help Article feed Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Privacy & Cookies

We use cookies and similar technologies

ResearchHub uses necessary technologies for security, authentication and core functionality. Advertising choices, where available, are collected separately through Google's consent message.

See our Privacy Notice and Cookie Policy.

Journal graph

Journal of Hematology & Oncology

Springer Science and Business Media LLC · ISSN 1756-8722

17

Verified works

0

Citations

—

Access

Researchers publishing here

2 linked researchers

Guillaume Cartron Ignacio Melero

Research in this journal

Mitochondrial genetic variation as a novel predictor of graft-versus-host disease after stem-cell transplantation in myelodysplastic neoplasms2026 · Shahram Arsang-Jang, Maryam Rafati, Yung-Tsi Bolon · 0 citations

Cytokine fusion proteins for solid tumor therapy: mechanistic insights and clinical advances2026 · Yufang Wang, Jingjing Qu, Yuqing Ren · 0 citations

High-definition spatial transcriptomics visualizes the cellular and molecular architecture underlying perineural invasion in localized prostate cancer2026 · Paul Vinu Salachan, Line Raaby, Jacob Fredsøe · 0 citations

Mucosal immunity: mechanism and application in cancer immunotherapy2026 · Maosen Xu, Ruolan Xia, Yuquan Wei · 0 citations

Glutathione reductase deficiency potentiates the immunogenicity of ferroptosis and cuproptosis via amplified reactive oxygen species accumulation and cGAS-STING pathway activation2026 · Zaidong Deng, Ruiqi Hu, Changheng Li · 0 citations

A phase 1 trial of CD123-directed chimeric antigen receptor T-cell therapy in adults with relapsed/refractory acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm2026 · Lihua E. Budde, Marissa M. Del Real, Joo Song · 0 citations

A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection2026 · Ángel Ramírez-Fernández, Adham S. Bear, Elahe Kamali · 0 citations

Copper homeostasis and cuproptosis rewire the tumor microenvironment: mechanisms, immune modulation, and therapeutic opportunities2026 · 0 citations

Cancer stem cell plasticity: mechanisms, immune microenvironment crosstalk, and therapeutic implications2026 · Jingyu Tan, Tao Wen, Xiaoli Ru · 0 citations

Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors2026 · Ignacio Melero, María de Miguel, Elena Garralda Cabanas · 0 citations

From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicine2026 · Liyuan Qiao, Leyang Wu, Yihan Xiao · 0 citations

Antibody-oligonucleotide conjugates: design principles, intracellular delivery, and translational opportunities2026 · Xinlin Liu, Daqiang Zhao · 0 citations

Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironment2026 · Yangzi Li, Shangkun Zhang, Zihan Gong · 0 citations

KRAS inhibition is an effective therapy for appendiceal adenocarcinoma2026 · Saikat Chowdhury, Ichiaki Ito, Vinay K. Pattalachinti · 0 citations

Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm2026 · Guillaume Cartron, Isabelle Chaillol, Roch Houot · 0 citations

Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study2026 · Alex Bataller, Courtney D. DiNardo, Sa A. Wang · 0 citations

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study2026 · Orianne Debeaupuis, Gandhi Damaj, Johannes Lübke · 0 citations